查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392006

CRISPR 基因组治疗市场：按产品类型、按应用、按最终用户、按地区

CRISPR Genomic Cure Market, By Product Type, By Application, By End User (Biopharmaceutical Companies, Contract Research Organizations, Genetic Research Laboratories, Others), By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球 CRISPR 基因组疗法市场规模预计将从 2023 年的 31.8 亿美元增至 2030 年的 117.1 亿美元，预测期内复合年增长率为 20.5%。

报告范围 报告详情
基准年 2022年 2023年市场规模 31.8亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 20.50% 2030年市场规模预测 117.1亿美元
图 1. 2023 年按地区分類的 CRISPR 基因组疗法的全球市场占有率(%)
CRISPR基因组治癒市场-IMG1

全球 CRISPR 基因组治疗市场是全球生物技术产业中快速发展的细分市场。 CRISPR（成簇规则间隔短回文重复序列）是一项突破性的基因编辑技术，可对基因组 DNA 进行定向的改变。这项技术有可能彻底改变多种疾病的治疗，包括遗传疾病、癌症和感染疾病。 CRISPR 基因组疗法市场是由遗传性疾病日益流行以及对有效治疗方法的需求不断增长所推动的。该技术能够以前所未有的精确度修改基因，为治疗以前认为无法治疗的疾病提供了新的可能性。此外，CRISPR技术的进步，例如开发更有效率、更安全的基因编辑工具，预计将进一步推动该市场的成长。增加研发活动投资以及扩大生物技术公司和研究机构之间的合作也有助于扩大全球 CRISPR 基因组治疗市场。然而，该市场面临一些挑战，包括与基因编辑相关的伦理和安全问题、监管障碍以及基于 CRISPR 的治疗方法的开发和商业化的高成本。儘管存在这些挑战，在该技术彻底改变医疗保健的巨大潜力的推动下，全球 CRISPR 基因组治疗市场预计在未来几年将显着增长。总之，全球 CRISPR 基因组治疗市场是一个充满前景且充满活力的市场，有潜力为各种疾病的治疗带来重大进展。

市场动态：

慢性病、遗传疾病、感染疾病、血液系统疾病、代谢性疾病的盛行率不断上升，老年人口不断增加，对安全有效的治疗和疗法、细胞和基因疗法的需求不断增加基因疗法的资金增加，基因疗法的频繁核准、新疗法的推出以及人们对全球 CRISPR 基因组治疗市场的认识不断提高是预计在预测期内促进全球 CRISPR 基因组治疗市场增长的关键因素。

例如，2021年3月，来自加州大学旧金山分校、加州大学柏克莱分校和加州大学洛杉矶分校（UCLA）的科学家启动了一项针对镰状病患者的CRISPR基因修饰疗法的初步研究，使用患者自身的造血干细胞获得美国食品药物管理局（FDA）核准，共同开始阶段人体临床试验。与目前健康骨髓捐赠者干细胞移植的治疗治疗方法相比，这种治疗方法有可能彻底改变镰状细胞疾病的治疗方法，创造出一种更安全、更容易获得和更有效的治疗方法。此外，这种治疗方法还可以预防镰状细胞疾病的不可逆併发症。

本研究的主要特点

  • 本报告对全球CRISPR基因组治疗市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年增长率。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、绩效和策略）介绍了全球 CRISPR 基因组治疗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
  • 全球 CRISPR 基因组治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球 CRISPR 基因组治疗市场的各种策略矩阵来促进他们的决策。

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球 CRISPR 基因组治疗市场 – 冠状冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球 CRISPR 基因组治疗市场，依产品类型，2018-2030

  • 介绍
  • 套件和试剂
  • 图书馆
  • 向量设计
  • 检测设计
  • 其他的

第六章 2018-2030 年全球 CRISPR 基因组治疗市场（按应用）

  • 介绍
  • 肿瘤学
  • 遗传疾病
  • 基因组工程
  • 其他的

第 7 章 2018-2030 年全球 CRISPR 基因组治疗市场（按最终用户）

  • 介绍
  • 生物製药公司
  • 受託研究机构（CRO）
  • 基因研究
  • 其他的

第8章2018-2030年全球CRISPR基因组治疗市场（按地区）

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 印度
  • 中国
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 亚太地区其他地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章竞争形势

  • Merck KgaA
  • Thermo Fisher Scientific Inc.
  • Origene Technologies, Inc.
  • New England Biolabs
  • Intellia Therapeutics, Inc.
  • GenScript
  • GeneCopoeia, Inc.
  • Cellectis
  • Mammoth Biosciences
  • Precision Biosciences, Inc.
  • Synthego Corporation
  • CRISPR Therapeutics
  • Horizon Discovery Group plc
  • Lonza Group Ltd.
  • Takara Bio Inc.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5856

The global CRISPR genomic cure market size is expected to reach US$ 11.71 Bn by 2030, from US$ 3.18 Bn in 2023, at a CAGR of 20.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.18 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 20.50% 2030 Value Projection: US$ 11.71 Bn
Figure 1. Global CRISPR Genomic Cure Market Share (%), by Region, 2023
CRISPR Genomic Cure Market - IMG1

The global CRISPR genomic cure market is a rapidly evolving sector within the global biotechnology industry. CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. This technology has the potential to transform the treatment of a wide range of diseases, including genetic disorders, cancers, and infectious diseases. The market for CRISPR genomic cures is driven by the increasing prevalence of genetic diseases and the growing demand for effective therapies. The technology's ability to modify genes with unprecedented precision has opened up new possibilities for the treatment of diseases that were previously considered untreatable. Moreover, advancements in CRISPR technology, such as the development of more efficient and safer gene-editing tools, are expected to further propel the growth of this market. The increasing investment in research and development activities, coupled with the growing collaboration between biotechnology companies and research institutes, is also contributing to the expansion of the global CRISPR genomic cure market. However, the market faces several challenges, including ethical and safety concerns related to gene editing, regulatory hurdles, and the high cost of developing and commercializing CRISPR-based therapies. Despite these challenges, the global CRISPR genomic cure market is expected to witness significant growth in the coming years, driven by the technology's immense potential to revolutionize healthcare. In conclusion, the global CRISPR genomic cure market represents a promising and dynamic field with the potential to bring about significant advancements in the treatment of various diseases.

Market Dynamics:

Increasing prevalence of chronic disease, genetic disease, infectious diseases, neurological disease, blood disease, and metabolic disease, a growing geriatric population, growing demand for safe and effective treatment or therapies, increasing funding for cell and gene therapies, frequent approvals for gene therapies, the introduction of novel therapies, and increasing awareness among people about the global CRISPR genomic cure market are major factors expected to augment the growth of the global CRISPR genomic cure market during the forecast period.

For instance, in March 2021, scientists at UC San Francisco, UC Berkeley, and UCLA received U.S. Food and Drug Administration (FDA) approval to jointly launch an early-phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The therapy has the potential to transform sickle cell disease care by producing an accessible, curative treatment that is safer than the current therapy of stem cell transplant from a healthy bone marrow donor. Moreover, the therapy has the potential to prevent irreversible complications of the disease.

Key features of the study:

  • This report provides in-depth analysis of the global CRISPR genomic cure market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., Takara Bio Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR genomic cure market

Detailed Segmentation:

  • By Product Type:
    • Kits & Reagents
    • Libraries
    • Vector Design
    • Assay Design
    • Others
  • By Application:
    • Oncology
    • Genetic Diseases
    • Genomic Engineering
    • Others
  • By End User:
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Genetic Research Laboratories
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Origene Technologies, Inc.
    • New England Biolabs
    • Intellia Therapeutics, Inc.
    • GenScript
    • GeneCopoeia, Inc.
    • Cellectis
    • Mammoth Biosciences
    • Precision Biosciences, Inc.
    • Synthego Corporation
    • CRISPR Therapeutics
    • Horizon Discovery Group plc
    • Lonza Group Ltd.
    • Takara Bio Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market CRISPR Genomic Cure Market, By Product Type
    • Market CRISPR Genomic Cure Market, By Application
    • Market CRISPR Genomic Cure Market, By End User
    • Market CRISPR Genomic Cure Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Genomic Cure Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global CRISPR Genomic Cure Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Libraries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Vector Design
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Assay Design
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global CRISPR Genomic Cure Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Genetic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Genomic Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global CRISPR Genomic Cure Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Genetic Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global CRISPR Genomic Cure Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • India
  • China
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of the APAC
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Merck KgaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
  • Origene Technologies, Inc.
  • New England Biolabs
  • Intellia Therapeutics, Inc.
  • GenScript
  • GeneCopoeia, Inc.
  • Cellectis
  • Mammoth Biosciences
  • Precision Biosciences, Inc.
  • Synthego Corporation
  • CRISPR Therapeutics
  • Horizon Discovery Group plc
  • Lonza Group Ltd.
  • Takara Bio Inc.
  • Analyst Views

10. Section

  • Research Methodology
  • About us